Selected research
Industry Research
Blood Plasma Industry Research Report 2026
Market perspective
The global Blood Plasma market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Blood Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Blood Plasma is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Blood Plasma is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Blood Plasma include Shanghai Raas, Baxter International, TCS Biosciences, Sanquin, Octapharma, Grifols, CSL, Cerus Corp and ADMA Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Blood Plasma market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Blood Plasma Market by Company
Shanghai Raas
Baxter International
TCS Biosciences
Sanquin
Octapharma
Grifols
CSL
Cerus Corp
ADMA Biologics
Blood Plasma Segment by Type
Protease Inhibitors
Coagulation Factor Concentrates
Immunoglobulin
Albumin
Others
Blood Plasma Segment by Application
Hospitals and Clinics
Research Laboratories
Academic Institutions
Blood Plasma Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Plasma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blood Plasma and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Plasma.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Blood Plasma manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Blood Plasma by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Blood Plasma in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Protease Inhibitors
- Coagulation Factor Concentrates
- Immunoglobulin
- Albumin
- Others
Applications
- Hospitals and Clinics
- Research Laboratories
- Academic Institutions
Companies covered
- Shanghai Raas
- Baxter International
- TCS Biosciences
- Sanquin
- Octapharma
- Grifols
- CSL
- Cerus Corp
- ADMA Biologics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Blood Plasma Market Size (2021-2032)
- 2.2.2 Global Blood Plasma Sales (2021-2032)
- 2.2.3 Global Blood Plasma Market Average Price (2021-2032)
- 2.3 Blood Plasma by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Protease Inhibitors
- 2.3.3 Coagulation Factor Concentrates
- 2.3.4 Immunoglobulin
- 2.3.5 Albumin
- 2.3.6 Others
- 2.4 Blood Plasma by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals and Clinics
- 2.4.3 Research Laboratories
- 2.4.4 Academic Institutions
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Blood Plasma Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Blood Plasma Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Blood Plasma Revenue of Manufacturers (2021-2026)
- 3.4 Global Blood Plasma Average Price by Manufacturers (2021-2026)
- 3.5 Global Blood Plasma Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Blood Plasma, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Blood Plasma, Product Type & Application
- 3.8 Global Manufacturers of Blood Plasma, Established Date
- 3.9 Global Blood Plasma Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Shanghai Raas
- 4.1.1 Shanghai Raas Company Information
- 4.1.2 Shanghai Raas Business Overview
- 4.1.3 Shanghai Raas Blood Plasma Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Shanghai Raas Blood Plasma Product Portfolio
- 4.1.5 Shanghai Raas Recent Developments
- 4.2 Baxter International
- 4.2.1 Baxter International Company Information
- 4.2.2 Baxter International Business Overview
- 4.2.3 Baxter International Blood Plasma Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Baxter International Blood Plasma Product Portfolio
- 4.2.5 Baxter International Recent Developments
- 4.3 TCS Biosciences
- 4.3.1 TCS Biosciences Company Information
- 4.3.2 TCS Biosciences Business Overview
- 4.3.3 TCS Biosciences Blood Plasma Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 TCS Biosciences Blood Plasma Product Portfolio
- 4.3.5 TCS Biosciences Recent Developments
- 4.4 Sanquin
- 4.4.1 Sanquin Company Information
- 4.4.2 Sanquin Business Overview
- 4.4.3 Sanquin Blood Plasma Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sanquin Blood Plasma Product Portfolio
- 4.4.5 Sanquin Recent Developments
- 4.5 Octapharma
- 4.5.1 Octapharma Company Information
- 4.5.2 Octapharma Business Overview
- 4.5.3 Octapharma Blood Plasma Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Octapharma Blood Plasma Product Portfolio
- 4.5.5 Octapharma Recent Developments
- 4.6 Grifols
- 4.6.1 Grifols Company Information
- 4.6.2 Grifols Business Overview
- 4.6.3 Grifols Blood Plasma Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Grifols Blood Plasma Product Portfolio
- 4.6.5 Grifols Recent Developments
- 4.7 CSL
- 4.7.1 CSL Company Information
- 4.7.2 CSL Business Overview
- 4.7.3 CSL Blood Plasma Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 CSL Blood Plasma Product Portfolio
- 4.7.5 CSL Recent Developments
- 4.8 Cerus Corp
- 4.8.1 Cerus Corp Company Information
- 4.8.2 Cerus Corp Business Overview
- 4.8.3 Cerus Corp Blood Plasma Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Cerus Corp Blood Plasma Product Portfolio
- 4.8.5 Cerus Corp Recent Developments
- 4.9 ADMA Biologics
- 4.9.1 ADMA Biologics Company Information
- 4.9.2 ADMA Biologics Business Overview
- 4.9.3 ADMA Biologics Blood Plasma Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 ADMA Biologics Blood Plasma Product Portfolio
- 4.9.5 ADMA Biologics Recent Developments
5 Global Blood Plasma Market Scenario by Region
- 5.1 Global Blood Plasma Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Blood Plasma Sales by Region: 2021-2032
- 5.2.1 Global Blood Plasma Sales by Region: 2021-2026
- 5.2.2 Global Blood Plasma Sales by Region: 2027-2032
- 5.3 Global Blood Plasma Revenue by Region: 2021-2032
- 5.3.1 Global Blood Plasma Revenue by Region: 2021-2026
- 5.3.2 Global Blood Plasma Revenue by Region: 2027-2032
- 5.4 North America Blood Plasma Market Facts & Figures by Country
- 5.4.1 North America Blood Plasma Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Blood Plasma Sales by Country (2021-2032)
- 5.4.3 North America Blood Plasma Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Blood Plasma Market Facts & Figures by Country
- 5.5.1 Europe Blood Plasma Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Blood Plasma Sales by Country (2021-2032)
- 5.5.3 Europe Blood Plasma Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Blood Plasma Market Facts & Figures by Country
- 5.6.1 Asia Pacific Blood Plasma Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Blood Plasma Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Blood Plasma Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Blood Plasma Market Facts & Figures by Country
- 5.7.1 South America Blood Plasma Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Blood Plasma Sales by Country (2021-2032)
- 5.7.3 South America Blood Plasma Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Blood Plasma Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Blood Plasma Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Blood Plasma Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Blood Plasma Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Blood Plasma Sales by Type (2021-2032)
- 6.1.1 Global Blood Plasma Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Blood Plasma Sales Market Share by Type (2021-2032)
- 6.2 Global Blood Plasma Revenue by Type (2021-2032)
- 6.2.1 Global Blood Plasma Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Blood Plasma Revenue Market Share by Type (2021-2032)
- 6.3 Global Blood Plasma Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Blood Plasma Sales by Application (2021-2032)
- 7.1.1 Global Blood Plasma Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Blood Plasma Sales Market Share by Application (2021-2032)
- 7.2 Global Blood Plasma Revenue by Application (2021-2032)
- 7.2.1 Global Blood Plasma Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Blood Plasma Revenue Market Share by Application (2021-2032)
- 7.3 Global Blood Plasma Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Blood Plasma Value Chain Analysis
- 8.1.1 Blood Plasma Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Blood Plasma Production Mode & Process
- 8.2 Blood Plasma Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Blood Plasma Distributors
- 8.2.3 Blood Plasma Customers
9 Global Blood Plasma Analyzing Market Dynamics
- 9.1 Blood Plasma Industry Trends
- 9.2 Blood Plasma Industry Drivers
- 9.3 Blood Plasma Industry Opportunities and Challenges
- 9.4 Blood Plasma Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst